Global Protein Expression Market Trends and Industry Analysis Report 2019

Global Protein Expression Market Trends and Industry Analysis Report 2019

According to the new market research report Protein Expression Market by Type (E. Coli, Mammalian, Yeast, Pichia, Insect, Baculovirus, Cell-free), Products (Competent Cells, Reagents, Instruments, Services), Application (Therapeutic, Research, Industrial) & End User — Global Forecast, published by MarketsandMarkets™.

The prevalence of chronic diseases, increasing research activities on recombinant-based proteins, and growing life sciences & biopharmaceutical industries are the major factors driving the growth of this market.

The high cost of protein expression instruments & reagents and increasing consolidation in the protein expression are the restraining factors for this market.

By systems type, the prokaryotic expression systems segment is expected to dominate the market in 2017

On the basis of systems type, the protein expression market is segmented into prokaryotic expression systems; insect cell expression systems; mammalian cell expression systems; yeast expression systems; cell-free expression systems; and algal-based expression systems.

Download PDF Brochure:https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180323924

The prokaryotic expression systems segment has been sub-segmented into Escherichia coli (E. coli) systems and other systems. The E. coli systems segment accounted for the largest share of this market segment. This growth can be attributed to the increasing use of E. coli systems to produce commercial proteins.

Browse and in-depth TOC on “Protein Expression Market”

127 — Tables

38 — Figures

173 — Pages

The objectives of this study are as follows:

  • To define, describe, and forecast the protein expression market on the basis of systems type, products, application, end user, and region
  • To provide detailed information regarding the major factors influencing growth of the market (drivers, restraints, opportunities and challenges)
  • To analyze micromarkets with respect to individual growth trends, prospects, and contributions to the overall market
  • To analyze the opportunities in the market for stakeholders and provide details of the competitive landscape for market leaders
  • To forecast revenue of the market segments with respect to four main regional segments, namely, North America, Europe, Asia, and the Rest of the World (RoW)

By product, the reagents segment is expected to hold the largest share of the market in 2017

The protein expression market is segmented into competent cells, expression vectors, instruments, reagents, and services on the basis of products. The reagents segment holds the largest share and also expected to grow at the highest growth rate during the forecast period. This positive growth trend is primarily attributed to increasing research activities and large-scale production of antibodies and vaccines that require kits and reagents.

The therapeutic applications segment is expected to dominate the market in 2017

By application, the protein expression market is segmented into therapeutic applications, research applications and industrial applications.The therapeutic applications segment holds the largest share in the market; however, the research applications segment is expected to grow at the highest growth rate during the forecast period. Growth in the research applications segment is primarily attributed to the increase in proteomics-based research activities around the world.

Request Research Sample Pages:

https://www.marketsandmarkets.com/requestsampleNew.asp?id=180323924

Protein Expression Market by Region

  • North America
  • Europe
  • Germany
  • France
  • U.K.
  • Asia
  • Rest of the World (RoW)

Key players operating in the protein expression market include Merck KGaA (Germany), Thermo Fisher Scientific Inc. (U.S.), Becton, Dickinson & Company (U.S.), Agilent Technologies, Inc. (U.S.), QIAGEN N.V. (Netherlands), Takara Bio Inc. (Japan), Lonza Group Ltd. (Switzerland), Bio-Rad Laboratories, Inc. (U.S.), GenScript Biotech Corporation (China), Lucigen Corporation (U.S.), Synthetic Genomics Inc. (U.S.), Promega Corporation (U.S.), New England Biolabs, Inc. (U.S.)

About Roberthenric

Images

Related Posts

Log in to post a comment.